Masahide Ota

Nara Medical University

Japan

  • Nara Medical University

SCHOLARLY PAPERS

1

DOWNLOADS

20

TOTAL CITATIONS

0

Scholarly Papers (1)

Actions:
Email selected abstracts
1.

A Phase II, Open Label, Single-Arm Study on the Efficacy of Cabozantinib in Patients with Advanced/Metastatic Nonsmall Cell Lung Cancer Harboring Met Exon 14 Alterations Who Developed Acquired Resistance to Tepotinib or Capmatinib (CAPTURE Trial)

Number of pages: 11 Posted: 29 Aug 2024
Masayuki Takeda, Masahide Ota, Eiji Iwama, Shunichi Sugawara, Takehito Shukuya, Shigeki Umemura, Hiroshi Tanaka, Masahide Oki, Takayuki Takahama, Takeshi Masuda, Naoyuki Nogami and Mototsugu Shimokawa
Kindai University, Nara Medical University, Kyushu University - Kyushu University Hospital, Sendai Kousei Hospital - Department of Pulmonary Medicine, Juntendo University, affiliation not provided to SSRN, Niigata Cancer Center Hospital, National Hospital Organization Nagoya Medical Center, Kindai University, Hiroshima University - Hiroshima University Hospital, Ehime University and Yamaguchi University
Downloads 20 (1,171,704)

Abstract:

Loading...

Lung cancer, MET, acquired resistance, cabozantinib, clinical trial